• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problems Gas Output Problem (1266); Pressure Problem (3012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/09/2023
Event Type  malfunction  
Manufacturer Narrative
Implanted date: requested, not provided.Explanted date: requested, not provided.The actual device has not been received yet for evaluation.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.The manufacturing record and the shipping inspection record of the actual product had no anomaly found.No other similar reports of the product with the involved product code/lot number were found.Terumo medical products (tmp) (importer) registration no: (b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
 
Event Description
The user facility reported that oxygenator did not perform to its normal functionality, struggled to get the po2 above 80%.Two perfusionists were present during the case.They continued to use the oxy just adding more o2 with a portable o2 tank.They had a difficult time getting the po2 above 80% when warming.The surgery did not stop.The issue was mitigated by using a 02 tank.The event occurred during a cardiopulmonary bypass.There was no delay in the procedure.The product was not changed out.They continued to use the involved product and finished the case with it.However, they were unable to get the desired po2 while using it during the case.The patient was not harmed and not affected, and no blood loss was reported.The surgery was completed successfully.Additional information was received on 22 feb 2023: the procedure was a common av valve repair, takedown of the bidirectional glenn, and central aortopulmonary shunt.
 
Manufacturer Narrative
This report is being submitted as follow-up no.1 to provide the device return date in section d9, to update section h3, and to provide the completed investigation results.The actual device has been returned for evaluation.Visual inspection of the actual sample upon receipt did not find any anomaly such as a breakage that could lead to gas transfer failure.After rinsing and drying the actual sample, the amount of oxygen transfer and carbon dioxide gas removal were measured according to the product inspection procedure.It was confirmed to meet the factory's specifications: bovine blood conditions hb: 12g/dl, temperature: 37°c., ph: 7.4, svo2: 65%, pvco2: 45mmhg.Circulation conditions: blood flow rate: 2l/ minute and 1l/ minute, v/q:1, fio2: 100%.O2 transfer volume at 2l/ minute: 130ml/ minute, at 1l/ minute: 69ml/ minute.Co2 removal volume at 2l/ minute: 103ml/minute, at 1l/ minute: 59ml/ minute.Review of the manufacturing record and the shipping inspection record of the actual sample confirmed that there was not any anomaly in them.A search of the complaint file found no other similar report of the product with the involved product code/lot number.Based on the investigation result, the gas transfer performance of actual sample after rinsing met the factory's specifications, and no anomaly were found in the manufacturing records.As a possible cause of occurrence, the complaint described that "when warming they had a difficult time getting the po2 above 80%", it was inferred that since rewarming stimulated the patient's metabolism, oxygen consumption increased and svo2 decreased.However, the cause of this case could not be clarified from the investigation result.For your reference, the instructions for use (ifu): (capiox fx05) of ashitaka factory has the following warning and precaution.Measure blood gases and make necessary adjustments as follows.Control pao2 by changing concentration of oxygen in ventilating gas using gas blender.To decrease pao2, decrease fio2.To increase pao2, increase fio2.Upon patient rewarming, adjust o2 concentration, gas flow rate and blood flow rate by increasing them as needed based on an increase in patient's metabolism.Failure to adjust the gas supply and the blood flow rate appropriately may cause insufficient o2 supply needed or the amount of the patient's gaseous metabolism.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
reg. no. 2243441
950 elkton blvd.
elkton, MD 21921
6402040886
MDR Report Key16526786
MDR Text Key311573248
Report Number9681834-2023-00040
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350739087
UDI-Public04987350739087
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071572
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number1CX*FX05RWA
Device Lot Number220608
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/09/2023
Initial Date FDA Received03/10/2023
Supplement Dates Manufacturer Received03/06/2023
Supplement Dates FDA Received04/03/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age7 MO
Patient SexFemale
Patient Weight6 KG
-
-